{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:30:44Z","timestamp":1760189444495,"version":"3.41.0"},"reference-count":30,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ABCD, arq. bras. cir. dig."],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:p>BACKGROUND: There is an improvement on the GIST treatment in last decade due to biomolecular research and adjuvant therapy with tyrosine kinases inibitors. However, both modalities of treatment rarely are available in Brazilian public hospital. AIM: Evaluate GIST patients profile in public oncologic hospital. METHODS: A retrospective study was made on patients with GIST diagnosed and treated between 2001 and 2013. RESULTS: Sixty-nine patients were included, mean age 59 years with slight predominance in females (51%). The main symptom was abdominal pain associated with incidental imaging finding. The occurrence of other associated neoplasm was in 28.8% of cases. The positivity of CD117 was 97.1%. The most frequent location was the stomach in 55.1% of cases. The R0 resection was possible in 63.8% and the recurrence rate was 20.3 %, with liver and peritoneum the main affected sites. Overall survival in the whole sample was 71%. Free survival rate of disease was 64%. The use of imatinib was limited to patients with residual disease (unresectable disease, R2 and R1 resection), metastatic disease or recurrence. CONCLUSION: In order to improve GIST treatment is necessary to add the biomolecular analysis to risk stratification. However, for this to occur, incentive in biomolecular research is required, to increase the possibility of patient survival.<\/jats:p>","DOI":"10.1590\/s0102-67202015000200010","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T23:23:47Z","timestamp":1436397827000},"page":"124-127","source":"Crossref","is-referenced-by-count":5,"title":["Profile of patients with gastrointestinal stromal tumors (GIST)"],"prefix":"10.1590","volume":"28","author":[{"given":"Eduardo Marcucci","family":"PRACUCHO","sequence":"first","affiliation":[{"name":"Amaral Carvalho Hospital, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Roberto","family":"LOPES","sequence":"additional","affiliation":[{"name":"Amaral Carvalho Hospital, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato Morato","family":"ZANATTO","sequence":"additional","affiliation":[{"name":"Amaral Carvalho Hospital, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla Thaisa","family":"TOMAL","sequence":"additional","affiliation":[{"name":"Amaral Carvalho Hospital, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celso Roberto","family":"PASSERI","sequence":"additional","affiliation":[{"name":"Amaral Carvalho Hospital, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel Roberto Sagioro","family":"MOLAN","sequence":"additional","affiliation":[{"name":"Amaral Carvalho Hospital, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari de Almeida","family":"PRADO","sequence":"additional","affiliation":[{"name":"Amaral Carvalho Hospital, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.semdp.2006.09.004","article-title":"Occurrence of other malignancies in patients with gastrointestinal stromal tumors","volume":"23","author":"Agaimy A","year":"2006","journal-title":"Semin Diagn Pathol"},{"key":"ref2","first-page":"220","article-title":"Mesenchymal tumors of the gut: Historical perspectives, new approaches, new results and does it make any difference?","volume":"31","author":"Appelman HD","year":"1990","journal-title":"Monogr Pathol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1200\/JCO.2007.13.4403","article-title":"Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT","volume":"26","author":"Blanke CD","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of Computed Tomography and Positron. Emission Tomography in Patients With Metastatic. Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New. Computed Tomography Response Criteria","volume":"25","author":"Choi H","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1200\/JCO.2004.05.140","article-title":"Biology of gastrointestinal stromal tumors","volume":"22","author":"Corless CL","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref6","first-page":"231","article-title":"Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival","author":"DeMatteo RP","year":"2000","journal-title":"Ann surg"},{"key":"ref7","series-title":"AJCC Cancer Staging Manual.","author":"Edge SE","year":"2010","edition":"7 \u00aa ed"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/hupa.2002.123545","article-title":"Diagnosis of gastrointestinal stromaltumors: A consensus approach","volume":"33","author":"Fletcher CD","year":"2002","journal-title":"Hum Pathol"},{"series-title":"Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation. A review of 200 cases to critically re-evaluate the concept of so-called extra-gastrointestinal stromal tumours","key":"ref9"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function of c-Kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota S","year":"1998","journal-title":"Science"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1827.2006.01924.x","article-title":"Pathology of gastrointestinal stromaltumors","volume":"56","author":"Hirota s","year":"2006","journal-title":"Pathol int"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.amjsurg.2006.10.033","article-title":"Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumors","volume":"194","author":"Hsu KH","year":"2007","journal-title":"Am J Surg"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.2012.347","article-title":"One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial","volume":"307","author":"Joensuu H","year":"2012","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.humpath.2008.06.025","article-title":"Risk stratification of patients diagnosed with gastrointestinal stromal tumor","volume":"39","author":"Joensuu H","year":"2008","journal-title":"Hum Pathol"},{"key":"ref15","first-page":"1259","article-title":"Gastrointestinal pacemaker cell tumor (GIPACT). Gastrointestinal strom tumors show phenotypic characteristics of the interstitial cells of Cajal","volume":"152","author":"Kindblom LG","year":"1998","journal-title":"Am J Pathol"},{"key":"ref16","first-page":"1259","article-title":"Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal","volume":"152","author":"Kindblom LG","year":"1998","journal-title":"Am J Pathol"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/PAS.0b013e318186b158","article-title":"Monoclonal antibody DOG1. 1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes","volume":"33","author":"Liegl B","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000478-198309000-00001","article-title":"Gastric stromal tumor. Reappraisal of histogenesis","volume":"7","author":"Mazur MT","year":"1983","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.5858\/2006-130-1466-GSTROM","article-title":"Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis","volume":"130","author":"Miettinen M","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.5858\/2006-130-1466-GSTROM","article-title":"Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis","volume":"130","author":"Miettinen M","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"ref21","first-page":"52","article-title":"Gastrointestinal stromal tumors of thestomach: a clinicopathologic, immunohisto- chemical, and molecular genetic study of 1765 cases with long-term follow-up","volume":"29","author":"Miettinen M","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.gtc.2013.01.001","article-title":"Gastrointestinal Stromal Turmors","volume":"42","author":"Miettinen M","year":"2013","journal-title":"Gastroenterol Clin N Am"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/path.1711640204","article-title":"Gastrointestinal stromal tumours: correlation of immunophenotype with clinicopathological features","volume":"164","author":"Newman PL","year":"1991","journal-title":"J Pathol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00000658-199201000-00010","article-title":"Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging","volume":"215","author":"Ng EH","year":"1992","journal-title":"Ann Surg"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/jnci\/djr130","article-title":"SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallelsequencing","volume":"103","author":"Pantaleo MA","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1097\/01.mph.0000157790.81329.47","article-title":"Gastrointestinal Stromal Tumors in Children and Young Adults. A Clinicopathologic, Molecular, and Genomic Study of 15 Cases and Review of theLiterature","volume":"27","author":"Prakash S","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MOG.0b013e32802086d0","article-title":"Current issues in gastrointestinal stromaltumors: incidence, molecular biology, and contemporary treatment of localized and advanced disease","volume":"23","author":"Raul CP","year":"2007","journal-title":"Current Opinion Gastroenterology"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/era.09.171","article-title":"Towards global consensus in the treatment of gastrointestinal stromal tumor","volume":"10","author":"Reichardt P","year":"2010","journal-title":"Expert Rev. AnticancerTher"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0002-9440(10)63279-8","article-title":"The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutationstatus","volume":"165","author":"West RB","year":"2004","journal-title":"Am J Pathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0092-8674(90)90297-R","article-title":"Identification of a ligand for the c-kit proto-oncogene","volume":"63","author":"Williams DE","year":"1990","journal-title":"Cell"}],"container-title":["ABCD. Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abcd\/v28n2\/0102-6720-abcd-28-02-00124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T03:01:32Z","timestamp":1748487692000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-67202015000200124&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0102-67202015000200124"],"URL":"https:\/\/doi.org\/10.1590\/s0102-67202015000200010","relation":{},"ISSN":["0102-6720"],"issn-type":[{"type":"electronic","value":"0102-6720"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}